Reliability and Utility of the Surprise Question in CKD Stages 4 to 5

Andrei D Javier1, Rocio Figueroa2, Edward D Siew1

  • 1Division of Nephrology and Hypertension, Vanderbilt University Medical Center, Nashville, TN; Vanderbilt Center for Kidney Disease, Nashville, TN.

Insights

The surprise question aids in predicting mortality for patients with advanced chronic kidney disease (CKD). This tool shows moderate to good reliability, supporting its use in care planning for non-dialysis-dependent CKD patients.

Area of Science:

  • Nephrology
  • Geriatrics
  • Palliative Care

Background:

  • Prognostic uncertainty hinders goals-of-care discussions in chronic kidney disease (CKD).
  • The surprise question is a tool to aid prognostication but lacks study in non-dialysis-dependent CKD.
  • Its reliability in this patient population is unknown.

Purpose of the Study:

  • To evaluate the surprise question's association with mortality in patients with non-dialysis-dependent CKD stages 4-5.
  • To assess the reliability (test-retest and inter-rater) of the surprise question in this population.

Main Methods:

  • Observational study of 388 patients (≥60 years) with non-dialysis-dependent CKD stages 4-5.
  • Utilized trinary (Yes, Neutral, No) and binary (Yes, No) surprise question responses.
  • Assessed mortality, test-retest reliability, and blinded inter-rater reliability, alongside baseline clinical factors.

Main Results:

  • Median age was 71 years; 13% of patients died during 1.4 years of follow-up.
  • Mortality rates differed significantly by surprise question response (5% for Yes, 15% for Neutral, 27% for No).
  • Trinary surprise question showed moderate to good reliability (inter-rater: 0.58, test-retest: 0.63) and moderate sensitivity/specificity for mortality.

Conclusions:

  • The surprise question is associated with mortality in advanced CKD stages 4-5.
  • The tool demonstrates moderate to good reliability in this population.
  • Further research is needed to optimize its use in advance care planning for non-dialysis-dependent CKD.
Abstract

Related Concept Videos

Chronic Kidney Disease III: Interprofessional Care01:28

Chronic Kidney Disease III: Interprofessional Care

Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
559
Chronic Kidney Disease I: Introduction01:25

Chronic Kidney Disease I: Introduction

Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...
912
Chronic Kidney Disease II: Clinical Manifestations01:24

Chronic Kidney Disease II: Clinical Manifestations

Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
842
Drug Dosing in Renal Diseases: Estimation of Glomerular Filtration Rate Based on Serum Creatinine Concentration01:28

Drug Dosing in Renal Diseases: Estimation of Glomerular Filtration Rate Based on Serum Creatinine Concentration

Glomerular filtration rate (GFR) can be estimated from serum creatinine using the modification of diet in renal disease (MDRD) formula or the chronic kidney disease–epidemiology collaboration (CKD–EPI) equation. Both methods are widely used in clinical practice to assess kidney function and guide treatment decisions.The MDRD equation does not require weight or height measurements and is normalized to the body surface area of 1.73 m², considered the average adult surface area.
285
Chronic Kidney Disease IV: Nursing Management01:18

Chronic Kidney Disease IV: Nursing Management

Nursing management is essential for preventing complications, maintaining stability, and improving patients' quality of life in chronic kidney disease (CKD). By using a structured approach, nurses help slow CKD progression and support effective patient care​.1. Comprehensive patient assessmentEffective management begins with nurses reviewing the patient’s medical history, and identifying key risk factors like diabetes, hypertension, and nephrotoxic drug use. Nurses assess signs of...
511
Acute Kidney Injury IV: Diagnostic Studies and Prevention01:30

Acute Kidney Injury IV: Diagnostic Studies and Prevention

Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
420